Lau Y S, Gnegy M E
J Pharmacol Exp Ther. 1980 Oct;215(1):28-34.
A calmodulin-binding assay was established in rat striatal particulates which were depleted of endogenous calcium and calmodulin by ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid (EGTA) treatment. The binding of 125I-labeled calmodulin to this preparation was saturable and time-dependent. The dependence of calmodulin binding upon temperature and concentration was also demonstrated. Calcium was a prerequisite for calmodulin binding and it facilitated the binding in a dose-dependent manner. Lanthanum, a known calcium antagonists in other tissue systems, mimicked the effect of calcium on calmodulin binding. When both ions were present at low concentrations, their effects on calmodulin binding was additive. Lanthanum, but not calcium, inhibited calmodulin release from a non-EGTA-treated preparation. This difference in action between calcium and lanthanum suggests that they mediate calmodulin binding in an independent manner. Scatchard analysis of calcium-calmodulin binding to rat striatal particulates revealed that there are two populations of binding sites: a higher affinity (apparent KD = 1.3 X 10(-7) M) and a lower affinity (apparent KD = 2.9 X 10(-7) M) binding site. Trifluoperazine, a phenothiazine antipsychotic drug, at 10(-4) M antagonized calmodulin binding only at the higher affinity binding sites. These sites may play an important role in mediating the action of trifluoperazine in the caudate nucleus.
通过用乙二醇双(β-氨基乙基醚)-N,N'-四乙酸(EGTA)处理,在去除内源性钙和钙调蛋白的大鼠纹状体微粒中建立了钙调蛋白结合试验。125I标记的钙调蛋白与该制剂的结合是可饱和的且具有时间依赖性。还证明了钙调蛋白结合对温度和浓度的依赖性。钙是钙调蛋白结合的先决条件,并且它以剂量依赖性方式促进结合。镧是其他组织系统中已知的钙拮抗剂,它模拟了钙对钙调蛋白结合的作用。当两种离子都以低浓度存在时,它们对钙调蛋白结合的作用是相加的。镧而非钙抑制了非EGTA处理制剂中钙调蛋白的释放。钙和镧在作用上的这种差异表明它们以独立的方式介导钙调蛋白结合。对大鼠纹状体微粒中钙-钙调蛋白结合的Scatchard分析表明存在两种结合位点:一种具有较高亲和力(表观KD = 1.3×10(-7)M)和一种较低亲和力(表观KD = 2.9×10(-7)M)的结合位点。三氟拉嗪是一种吩噻嗪类抗精神病药物,在10(-4)M时仅在较高亲和力结合位点拮抗钙调蛋白结合。这些位点可能在介导三氟拉嗪在尾状核中的作用中起重要作用。